Abstract:Background: Mutations in the Spleen tyrosine kinase (Syk) protein have significant implications for its function and response to treatments. Understanding these mutations and identifying new inhibitors can lead to more effective therapies for conditions like autosomal dominant hyper-IgE syndrome (AD-HIES) and related immunological disorders. Objective: To investigate the impact of mutations in the Syk protein on its function and response to reference treatments, and to explore new inhibitors tailored to the mutational profile of Syk. Methods: We collected and analyzed mutations affecting the Syk protein to assess their functional impact. We screened 94 deleterious mutations in the kinase domain using molecular docking techniques. A library of 997 compounds with potential inhibitory activity against Syk was filtered based on Lipinski and Veber rules and toxicity assessments. We evaluated the binding affinity of reference inhibitors and 14 eligible compounds against wild-type and mutant Syk proteins. Molecular dynamics simulations were conducted to evaluate the interaction of Syk protein complexes with the reference inhibitor and potential candidate inhibitors. Results: Among the analyzed mutations, 60.5% were identified as deleterious, underscoring their potential impact on cellular processes. Virtual screening identified three potential inhibitors (IDs: 118558008, 118558000, and 118558092) with greater therapeutic potential than reference treatments, meeting all criteria and exhibiting lower IC50 values. Ligand 1 (ID: 118558000) demonstrated the most stable binding, favorable compactness, and extensive interaction with solvents. A 3D pharmacophore model was constructed, identifying structural features common to these inhibitors. Conclusion: This study found that 60.5% of reported mutations affecting the Syk protein are deleterious. Virtual screening revealed three top potential inhibitors, with ligand 1 (ID: 118558000) showing the most stable binding and favorable interactions. These inhibitors hold promise for more effective therapies targeting Syk-mediated signaling pathways. The pharmacophore model provides valuable insights for developing targeted therapies for AD-HIES and related disorders, offering hope for patients suffering from Hyper IgE syndrome with allergic symptoms.

Sesamin is an Effective Spleen Tyrosine Kinase Inhibitor Against IgE-mediated Food Allergy in Computational, Cell-Based and Animal Studies

A novel natural Syk inhibitor suppresses IgE-mediated mast cell activation and passive cutaneous anaphylaxis

Sesamin Attenuates Mast Cell-Mediated Allergic Responses by Suppressing the Activation of P38 and Nuclear Factor-Κb.

Sesamin Attenuates Allergic Airway Inflammation Through the Suppression of Nuclear Factor-Kappa B Activation.

Sesamin suppresses mast cell activation through inhibition of PKCα/NF-κB signaling pathway

Anxiolytic Effects of Sesamin in Mice with Chronic Inflammatory Pain

Sesamin Alleviates Asthma Airway Inflammation by Regulating Mitophagy and Mitochondrial Apoptosis.

Sesamin attenuates inflammation response in a murine model of asthma

Seselin Ameliorates Inflammation Via Targeting Jak2 to Suppress the Proinflammatory Phenotype of Macrophages

Sesamin Protects Against Dss-Induced Colitis In Mice By Inhibiting Nf-Kappa B And Mapk Signaling Pathways

TAS05567, a Novel Potent and Selective Spleen Tyrosine Kinase Inhibitor, Abrogates Immunoglobulin-Mediated Autoimmune and Allergic Reactions in Rodent Models

Role of Selenium in IgE Mediated Soybean Allergy Development.

Sesamin Enhances Nrf2-Mediated Protective Defense Against Oxidative Stress and Inflammation in Colitis Via AKT and ERK Activation.

Exploring the allergenic potential of sesame oleosins: Isolation and bioinformatics analysis

Saikosaponin-d Inhibits Β-Conglycinin Induced Activation of Rat Basophilic Leukemia-2H3 Cells

SG-SP1 Suppresses Mast Cell-Mediated Allergic Inflammation via Inhibition of FcεRI Signaling

Translational Selenium Nanoparticles to Attenuate Allergic Dermatitis Through Nrf2-Keap1-Driven Activation of Selenoproteins.

Syk protein inhibitors treatment for the allergic symptoms associated with hyper immunoglobulin E syndromes: A focused on a computational approach

Sea Buckthorn Flavonoid Extracted with High Hydrostatic Pressure Alleviated Shrimp Allergy in Mice Through the Microbiota and Metabolism

Combinatorial advantage of Ses i 1-specific IgE and basophil activation for diagnosis of sesame food allergy

Saikosaponin A Inhibits Compound 48/80-Induced Pseudo-Allergy Via the Mrgprx2 Pathway in Vitro and in Vivo